Dual A2aR/A2bR Antagonism with Etrumadenant Blocks the Immunosuppressive Effects of Adenosine & Enhances Anti-Tumor Immune Responses

Time: 9:30 am
day: Day Two

Details:

  • Exploring the preclinical characterization of dual A2aR/A2bR antagonist etrumadenant
  • Investigating A2aR selective vs dual A2aR/A2bR antagonism in adenosine-mediated suppression of myeloid cell activity

Speakers: